The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection

J Virol. 2021 May 24;95(12):e00434-21. doi: 10.1128/JVI.00434-21. Print 2021 May 24.

¹ Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
² Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan.
³ Section of Oncopathology and Regenerative Biology, Faculty of Medicine, Department of Pathology, University of Miyazaki, Miyazaki, Japan.
⁴ Laboratory of Medical Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
⁵ Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan mtakeda@nih.go.jp.

No abstract available

Keywords: HAI-2; SARS-CoV-2; TMPRSS2.

Publication types